196 related articles for article (PubMed ID: 19173015)
1. Aberrant p63 and WT-1 expression in myoepithelial cells of pregnancy-associated breast cancer: implications for tumor aggressiveness and invasiveness.
Xu Z; Wang W; Deng CX; Man YG
Int J Biol Sci; 2009; 5(1):82-96. PubMed ID: 19173015
[TBL] [Abstract][Full Text] [Related]
2. Increased invasiveness and aggressiveness in breast epithelia with cytoplasmic p63 expression.
Hsiao YH; Su YA; Tsai HD; Mason JT; Chou MC; Man YG
Int J Biol Sci; 2010 Aug; 6(5):428-42. PubMed ID: 20714441
[TBL] [Abstract][Full Text] [Related]
3. Hidden malignant cells within leukocyte aggregates: seeds for invasive and metastatic cancer?
Hsiao YH; Deng C; Mason JT; Chou MC; Man YG
Cancer Epidemiol; 2011 Oct; 35(5):475-9. PubMed ID: 21292584
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain.
Werling RW; Hwang H; Yaziji H; Gown AM
Am J Surg Pathol; 2003 Jan; 27(1):82-90. PubMed ID: 12502930
[TBL] [Abstract][Full Text] [Related]
5. Morphometric analysis and p63 improve the identification of myoepithelial cells in breast lesion cytology.
Aikawa E; Kawahara A; Kondo K; Hattori S; Kage M
Diagn Cytopathol; 2011 Mar; 39(3):172-6. PubMed ID: 21319317
[TBL] [Abstract][Full Text] [Related]
6. The relationship between p63 and p53 expression in normal and neoplastic breast tissue.
Ribeiro-Silva A; Zambelli Ramalho LN; Britto Garcia S; Zucoloto S
Arch Pathol Lab Med; 2003 Mar; 127(3):336-40. PubMed ID: 12653579
[TBL] [Abstract][Full Text] [Related]
7. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast.
Reis-Filho JS; Milanezi F; Paredes J; Silva P; Pereira EM; Maeda SA; de Carvalho LV; Schmitt FC
Appl Immunohistochem Mol Morphol; 2003 Mar; 11(1):1-8. PubMed ID: 12610349
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and Functional Characterization of Ductal Carcinoma In Situ-Associated Myoepithelial Cells.
Rohilla M; Bal A; Singh G; Joshi K
Clin Breast Cancer; 2015 Oct; 15(5):335-42. PubMed ID: 25700939
[TBL] [Abstract][Full Text] [Related]
9. Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion.
Man YG; Tai L; Barner R; Vang R; Saenger JS; Shekitka KM; Bratthauer GL; Wheeler DT; Liang CY; Vinh TN; Strauss BL
Breast Cancer Res; 2003; 5(6):R231-41. PubMed ID: 14580259
[TBL] [Abstract][Full Text] [Related]
10. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
11. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of p63 protein and calponin in canine mammary tumours.
Łopuszyński W; Szczubiał M; Millán Y; Guil-Luna S; Sánchez-Céspedes R; Martin de Las Mulas J; Śmiech A; Bulak K
Res Vet Sci; 2019 Apr; 123():232-238. PubMed ID: 30685648
[TBL] [Abstract][Full Text] [Related]
13. WT1 expression in salivary gland pleomorphic adenomas: a reliable marker of the neoplastic myoepithelium.
Langman G; Andrews CL; Weissferdt A
Mod Pathol; 2011 Feb; 24(2):168-74. PubMed ID: 21057459
[TBL] [Abstract][Full Text] [Related]
14. Naked nuclei revisited: p63 Immunoexpression.
Reis-Filho JS; Albergaria A; Milanezi F; Amendoeira I; Schmitt FC
Diagn Cytopathol; 2002 Sep; 27(3):135-8. PubMed ID: 12203858
[TBL] [Abstract][Full Text] [Related]
15. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
[TBL] [Abstract][Full Text] [Related]
16. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
17. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
18. Aberrant c-erbB2 expression in cell clusters overlying focally disrupted breast myoepithelial cell layers: a trigger or sign for emergence of more aggressive cell clones?
Zhang X; Hashemi SS; Yousefi M; Ni J; Wang Q; Gao L; Gong P; Gao C; Sheng J; Mason J; Man YG
Int J Biol Sci; 2008 Aug; 4(5):259-69. PubMed ID: 18726004
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of tumor-infiltrating immune cells on basal and luminal cells: implications for tumor invasion and metastasis.
Song G; Hsiao H; Wang JL; Mannion C; Stojadinovic A; Avital I; Fu SW; Mason J; Chen W; Jewett A; Li H; Man YG
Anticancer Res; 2014 Nov; 34(11):6363-80. PubMed ID: 25368236
[TBL] [Abstract][Full Text] [Related]
20. Myoepithelial cells in lobular carcinoma in situ: distribution and immunophenotype.
Wang Y; Jindal S; Martel M; Wu Y; Schedin P; Troxell M
Hum Pathol; 2016 Sep; 55():126-34. PubMed ID: 27195907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
